Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 79 recruiting now early-phase tilt #32 of 28,707 conditions

Healthy Volunteers: early-phase trial registry

79 of 284 indexed Healthy Volunteers trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #32 of 28,707 conditions by registered trial count.

284 US clinical trials · 79 currently recruiting · #32 of 28,707 conditions by registered trial count

Healthy Volunteers: 284 US clinical trials tracked, 79 recruiting.

Healthy Volunteers is the subject of 284 registered US clinical trials on ClinicalTrials.gov, 79 of them currently open to new participants. 6 are in Phase 3-4 (later-stage) and 206 in Phase 1-2 (earlier-stage). The most active sponsor is Takeda, running 16 of these trials.

Enrollment posture brief

Registry condition healthy-volunteers

OPEN 79 | RECR 28% | LATE 6 | EARLY 206 | RANK #32 | SPON 16

Nearest open-share peer: Arrhythmias, Cardiac (28% recruiting · 18 trials)

Parkinson Disease45.3%Major Depressive Disorder38.5%Pancreatic Cancer35.7%Healthy Volunteers (this)28%Leukemia18.6%
Open-enrollment share among volume-matched conditions near Healthy Volunteers

Healthy Volunteers lists 79 open slots (28% of 284 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Healthy Volunteers on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Healthy Volunteers is recruiting below its size-band peers.

    79 of 284 indexed trials (27.8%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Healthy Volunteers trials is spread across many organizations.

    Takeda accounts for 16 of 284 trials (5.6%). 144 distinct sponsors appear on at least one study for this condition label.

  3. Most Healthy Volunteers trials plan to enrol fewer than 100 people.

    Median target enrolment is 48 among the 284 trials that report a genuine target (sentinel values excluded). 204 of those (71.8%) plan for fewer than 100 participants.

  4. Healthy Volunteers research is mostly interventional.

    251 interventional and 33 observational studies make up this index (88.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 1198Phase 28Phase 46

Open and recent trials

284 total, page 4 of 6

COMPLETED Phase 1 59 participants

Cumulative Irritation Potential of 828 Ointment

Healthpoint

NCT00767455

COMPLETED Phase 1 58 participants

A Study to Evaluate the Safety, Tolerability and Amount of EI-1071 in Blood in Healthy Volunteers

Elixiron Immunotherapeutics (Hong Kong)

NCT04238364

COMPLETED Phase 1 58 participants

Photoallergy Potential of Dapsone Gel in Healthy Volunteers

Almirall, S.A.

NCT02117739

COMPLETED Phase 1 58 participants

Evaluate Effects of Multiple Doses of Rifampin and Clarithromycin on the Single Dose Pharmacokinetics of Deflazacort

PTC Therapeutics

NCT02286635

COMPLETED Phase 1 57 participants

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AJ302-IM in Healthy Volunteers

AnnJi Pharmaceutical Co.

NCT06625541

COMPLETED Phase 1 57 participants

Study to Investigate the Effect of Balovaptan on the QTC Interval in Healthy Subjects

Hoffmann-La Roche

NCT03808298

COMPLETED Phase 1 56 participants

A Study to Evaluate the Antibody Response of Influenza Vaccination Following Concomitant Exposure to Bimekizumab in Healthy Subjects

UCB Biopharma S.P.R.L.

NCT03895385

COMPLETED Phase 1 56 participants

Study of AC0058TA in Healthy Male and Female Subjects

ACEA Therapeutics

NCT02847325

COMPLETED Phase 1 56 participants

A Phase I Study in Healthy Volunteers to Assess the Effect of Cytochrome3A4 (CYP3A4) Inhibitors (Diltiazem and Itraconazole) on the Pharmacokinetics (PK) of AZD3293 and the Effects of AZD3293 on the Pharmacokinetics of Midazolam, a Cytochrome 3A4 and Cytochrome 3A5 (CYP3A4/CYP3A5) Substrate

AstraZeneca

NCT02010970

COMPLETED Phase 1 54 participants

Drug-drug Interaction Study of Ozanimod With Pseudoephedrine to Evaluate the Effect on Blood Pressure and Heart Rate

Celgene

NCT03644576

COMPLETED Phase 1 52 participants

A Study to Determine the Effect of Food on the Pharmacokinetics of PCI-32765

Janssen Research & Development

NCT01820936

COMPLETED Phase 1 52 participants

A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components

Janssen Research & Development

NCT02073227

COMPLETED Phase 1 50 participants

Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT00862433

COMPLETED Phase 1 50 participants

Use of MRI for Assessing Stomach Relaxation in Response to a Meal

Mayo Clinic

NCT00275743

COMPLETED Phase 1 50 participants

A Study to Investigate Different Formulations of S-337395 in Healthy Adult Participants

Shionogi

NCT06270511

COMPLETED Phase 1 49 participants

Study to Assess the Safety and Tolerability of Ascending Single Doses of REGN2009 in Healthy Volunteers

Regeneron Pharmaceuticals

NCT01893528

COMPLETED Phase 1 48 participants

Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITI 333 in Healthy Volunteers

Intra-Cellular Therapies

NCT04934124

COMPLETED Phase 1 48 participants

Japanese Pharmacokinetic Bridging Study for CC-93538

Celgene

NCT04096105

COMPLETED Phase 2 47 participants

Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT01950520

COMPLETED Phase 1 46 participants

A Study to Access Safety, Tolerability, Pharmacokinetics(PK) and Pharmacodynamics(PD) of Orally Administered GCC-4401C in Healthy Volunteers

Green Cross Corporation

NCT01954238

COMPLETED Phase 1 45 participants

Food Effect and Bioavailability of Deflazacort Formulations in Healthy Volunteers

PTC Therapeutics

NCT02485431

COMPLETED Phase 1 42 participants

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of BMS-986278 and the Effects of BMS-986278 on Cardiac Repolarization in Healthy Participants

Bristol-Myers Squibb

NCT06746402

COMPLETED Phase 1 40 participants

Safety Study of Efprezimod Alfa (CD24Fc, MK-7110) When Administered Intravenously in Healthy Adult Subjects (MK-7110-001)

Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

NCT02650895

COMPLETED Phase 1 40 participants

Compare the Same Dosage of Insulin Using a Combination of Cartridges, 30 Units as 2 Cartridges vs. 1 Cartridge

Mannkind Corporation

NCT01902121

COMPLETED Phase 1 40 participants

Safety and Tolerability of Escalating Doses of BPN-14967 in Healthy Adults

Belite Bio

NCT04005807

COMPLETED Phase 1 40 participants

A Study to Assess the Absorption of a Single Dose of BMS-986205 in Healthy Volunteers When Administered as a Crushed Tablet Orally or Crushed Tablet Suspension Via Nasogastric Tube, as Compared to a Tablet

Bristol-Myers Squibb

NCT03362411

COMPLETED Phase 1 40 participants

A Study to Assess Safety, Tolerability, and Pharmacokinetics of CC-92480 Formulations in Healthy Adult Participants

Celgene

NCT04839809

COMPLETED NA 39 participants

A Study to Evaluate Nicotine Uptake and Biomarkers in Adult Smokers Using mybluTM Electronic Cigarettes

Fontem US

NCT04429932

COMPLETED Phase 1 39 participants

Civamide Patch Safety, Tolerability and PK Study

Winston Laboratories

NCT00758433

COMPLETED Phase 1 39 participants

A Study to Evaluate the Effect of Co-administration on the Pharmacokinetics of SPR720, Azithromycin, and Ethambutol in Healthy Participants

Spero Therapeutics

NCT05966688

COMPLETED Phase 1 38 participants

A Study to Assess the Pharmacokinetics and Safety of CSL312 in Healthy Japanese and Caucasian Adults

CSL Behring

NCT04580654

COMPLETED NA 37 participants

Effects of Rehabilitation Robots-Morning Walk in Individuals With Hemiparesis

The University of Texas Medical Branch, Galveston

NCT06374706

COMPLETED Phase 1 36 participants

A Open-label, Three-period, Partial-replicate Design Study to Evaluate the Inter- and Intrasubject Variability of the Avatrombopag To-be-marketed Formulation Administered as Single Doses of 40 mg to Healthy Subjects Receiving a Low-fat Meal

Eisai

NCT01759394

COMPLETED Phase 1 36 participants

A Study of Soticlestat in Adults With Liver Failure Compared to Those With Normal Liver Function

Takeda

NCT05098054

COMPLETED Phase 1 36 participants

Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects

Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)

NCT01702649

COMPLETED NA 36 participants

ID-Cap System Under Direct Observation

EtectRX

NCT03475485

COMPLETED NA 35 participants

Evaluation of Changes to Skin Microbiome With Tape-Stripped Wounds

Johnson & Johnson Consumer Inc. (J&JCI)

NCT03365934

COMPLETED Phase 1 32 participants

A Study of RGLS8429 in Healthy Volunteers

Regulus Therapeutics

NCT05429073

COMPLETED Phase 1 32 participants

A Study to Assess the Safety and Tolerability of E2730 After Multiple Dose and the Food Effect After Single Dose in Healthy Participants

Eisai

NCT04676685

COMPLETED Phase 1 32 participants

A Phase 1 Study to Assess Single and Multiple Ascending Doses of PBI-100 Topical Cream

Pyramid Biosciences

NCT05514353

COMPLETED Phase 1 32 participants

A Study to Assess the Relative Bioavailability and Effect of Food on the Coated Granule Formulation of Mitapivat in Healthy Participants

Agios Pharmaceuticals

NCT04565678

COMPLETED Phase 1 32 participants

A Study of Single Ascending Doses of IW-3300 in Healthy Volunteers

Ironwood Pharmaceuticals

NCT05188261

COMPLETED Phase 1 32 participants

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of E2025 in Healthy Participants

Eisai

NCT05726851

COMPLETED Phase 1 32 participants

A Study of Maribavir Pediatric Formulation in Healthy Adult Participants

Takeda

NCT05918822

COMPLETED Phase 1 32 participants

Study of Lanadelumab in Healthy Japanese and Matched Caucasian Adult Subjects

Shire

NCT03401671

COMPLETED Phase 1 32 participants

The Effects of GLA on Human Volunteers

Rockefeller University

NCT01397604

COMPLETED Phase 1 32 participants

Effect of Repeated Oral Doses of Avacopan on the Pharmacokinetics (PK) of a Single Dose of Simvastatin

Amgen

NCT06207682

COMPLETED Phase 1 32 participants

Effect of Rifampin and Efavirenz on the Pharmacokinetics of Fedratinib in Healthy Adult Subjects

Celgene

NCT03983239

COMPLETED Phase 1 32 participants

Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITI 333 in Healthy Volunteers

Intra-Cellular Therapies

NCT05732194

COMPLETED Phase 1 32 participants

A Study to Assess the Effect of Voriconazole and Quinidine on the Pharmacokinetics of a Single Dose of Repotrectinib in Healthy Participants

Bristol-Myers Squibb

NCT06493409

← Previous Page 4 of 6 Next →

Phase Distribution

PhaseTrial count
Phase 1 198
Phase 2 8
Phase 4 6

Named interventions

Most-linked intervention names on Healthy Volunteers records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
38 trials
Placebo Other
8 trials
Midazolam Drug
6 trials
Moxifloxacin Drug
5 trials
Itraconazole Drug
5 trials
Digoxin Drug
4 trials
Isavuconazole Drug
3 trials
Vedolizumab SC Drug
3 trials

US sites by state

Facility locations filed on Healthy Volunteers trials. A trial with sites in several states counts in each.

Maryland 56 trials
Texas 46 trials
Florida 39 trials
California 35 trials
Arizona 22 trials
Wisconsin 13 trials
New Jersey 12 trials
Kansas 11 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Healthy Volunteers page

284 registered trials, 79 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 79 Healthy Volunteers trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Takeda sponsors the most Healthy Volunteers trials on record, review their full trial history before evaluating a specific study. See Takeda's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Healthy Volunteers condition card totals 284 registered trials; most-linked intervention Placebo; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.